ProQR Therapeutics N.V. (PRQR)
Last updated: 2026-10-21 20:38:40. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Summary
ProQR Therapeutics N.V. (PRQR) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $1.37, with a market capitalization of $184.87M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.30 to $3.10. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$184.87M | |
$1.38 | |
$27.60 | |
$0.53 | |
$1.38 | |
631.64K | |
805.68K | |
-- | |
$3.10 | |
$1.30 | |
-- | |
-- |
ProQR Therapeutics N.V. (PRQR) After-Hours Stock Price
ProQR Therapeutics N.V. (PRQR) is trading at $1.37 in after-hours trading as of 2026-10-21 19:59:59, down 1.09% ($0.01) from the regular-session close of $1.38.
After-hours trading shows how investors are pricing PRQR after the regular session closes. The current after-hours price is below the regular-session close, indicating cautious after-hours sentiment.
ProQR Therapeutics N.V. (PRQR) 7-Day Stock Price Change
Over the past seven days, ProQR Therapeutics N.V. (PRQR) moved from $1.62 to $1.37, representing a decline of 15.68% ($0.25).
The stock traded between $1.30 and $1.70 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 1.06 million shares, up versus the previous seven-day period, indicating higher trading activity.
PRQR 52-Week Price Position
Position in Range: 3.7%
PRQR is currently trading at $1.37, placing it 3.7% of the way from its 52-week low of $1.30 to its 52-week high of $3.10. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is ProQR Therapeutics N.V. (PRQR)?
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.
ProQR Therapeutics N.V. Information
| Employees | 187 |
| Exchange | NASDAQ |
| Company Website |
How to Buy ProQR Therapeutics N.V. (PRQR) Stock on MEXC
Eligible investors can buy real shares of ProQR Therapeutics N.V. (PRQR) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is ProQR Therapeutics N.V. (PRQR) stock price today?
2.Is PRQR stock going up or down today?
3.What is PRQR pre-market price?
4.What is PRQR after-hours price?
5.Is PRQR stock trading now?
6.Where does PRQR sit relative to its 52-week high and low?
7.What sector is ProQR Therapeutics N.V. in?
8.What is ProQR Therapeutics N.V.'s market capitalization and where is it listed?
9.How is PRQR valued in terms of P/E ratio and EPS?
10.Does ProQR Therapeutics N.V. pay a dividend?
Explore More US Stocks
Search Stocks
PRQR Stock Calculator
Estimate the value between PRQR shares and USD.
PRQR Shares to USD
1.00 PRQR shares = 1.366 USD
Calculations are estimates based on the latest available price and are for reference only.



